Can I read Barbara M Mcgowan Efficacy and Safety of Once Weekly on EtoBox?
Barbara M Mcgowan Efficacy and Safety of Once Weekly by yeimerortizm is a document available to read on EtoBox.
What is Barbara M Mcgowan Efficacy and Safety of Once Weekly about?
The STEP 10 trial assessed the efficacy and safety of once-weekly semaglutide 2·4 mg compared to placebo in individuals with obesity and prediabetes. Results showed significant weight reduction and higher rates of reversion to normoglycaemia in the semaglutide group, with a favorable safety profile consistent with previous studies. These findings suggest semaglutide 2·4 mg as a viable treatment option for managing obesity and improving glycaemic control in this population.
- Author
- yeimerortizm
- Language
- EN